Valuation dashboard for Lisata Therapeutics, Inc. (LSTA) with P/E N/A, P/B 0.97, EV/EBITDA -0.01 and dividend yield 0.00%. DCF, Graham Number and Earnings Power Value models plus sector comparison against other Healthcare companies.
Lisata Therapeutics, Inc. is a clinical-stage biopharmaceutical firm focused on pioneering and bringing to market cellular therapies. These treatments are designed to either reverse disease progression or facilitate the repair of damaged bodily tissues.
Analysis Summary
Trailing-twelve-month margins: gross margin 14.1%, operating margin -107.1%, net margin -97.6%.
At the current price of $1.47, LSTA has negative trailing earnings (P/E not meaningful) and an ROE of -111.65%. Market capitalisation stands at $13M.
Balance sheet quality for LSTA: current ratio of 5.8. A debt-to-equity below 1.0 typically signals conservative capital structure, while a current ratio above 1.5 indicates comfortable short-term liquidity.
Valuation Ratios
| Price / Book | 0.97 |
| EV / EBITDA | -0.01 |
| Dividend Yield | 0.00% |
Valuation Models
| DCF Fair Value | $1.91 |
| vs Current Price | +29.9% |
Peer Comparison
| Symbol | Company | Market Cap | P/E | P/B | ROE |
|---|---|---|---|---|---|
| LSTA | Lisata Therapeutics, Inc. | $13M | 0.97 | -111.7% | |
| 0QZU.L | Vertex Pharmaceuticals Incorporated | $131.8B | |||
| VRTX | Vertex Pharmaceuticals Incorporated | $130.6B | 29.76 | 6.46 | 23.3% |
| 0R2M.L | Regeneron Pharmaceuticals, Inc. | $84.0B | |||
| REGN | Regeneron Pharmaceuticals, Inc. | $79.8B | 18.79 | 2.57 | 13.8% |
| ARGX | argenx SE | $61.2B | 36.30 | 7.40 | 21.7% |
| MRNA | Moderna, Inc. | $57.8B | 1.34 | -39.2% | |
| RVMD | Revolution Medicines, Inc. | $41.7B | 15.96 | -96.4% |
Price
| Price | $1.47 |
| Market Cap | $13M |
| Exchange | NASDAQ |
| Country | US |
Profitability
| Return on Equity | -111.65% |
| Return on Invested Capital | -117.30% |
| Return on Assets | -93.47% |
| Gross Margin | 14.12% |
| Operating Margin | -10711.18% |
| Net Margin | -9756.47% |
Related companies: CASI · CLGN · CLSD · ENLV · KLTO · MTVA · NCNA
Explore sector: Healthcare · Biotechnology
More sections of LSTA: Overview · Financials · Statistics · Estimates · Technical · Ownership · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks